- Home
- SNES vs INM Comparison
SNES vs INM Comparison
Compare SNES & INM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNES
- INM
- Stock Information
- Founded
- SNES 2004
- INM 1981
- Country
- SNES United States
- INM Canada
- Employees
- SNES N/A
- INM N/A
- Industry
- SNES Agricultural Chemicals
- INM Biotechnology: Pharmaceutical Preparations
- Sector
- SNES Industrials
- INM Health Care
- Exchange
- SNES Nasdaq
- INM Nasdaq
- Market Cap
- SNES 6.7M
- INM 3.2M
- IPO Year
- SNES 2016
- INM N/A
- Fundamental
- Price
- SNES $5.06
- INM $3.32
- Analyst Decision
- SNES Strong Buy
- INM
- Analyst Count
- SNES 1
- INM 0
- Target Price
- SNES $10.00
- INM N/A
- AVG Volume (30 Days)
- SNES 244.6K
- INM 9.5M
- Earning Date
- SNES 08-07-2025
- INM 05-12-2025
- Dividend Yield
- SNES N/A
- INM N/A
- EPS Growth
- SNES N/A
- INM N/A
- EPS
- SNES N/A
- INM N/A
- Revenue
- SNES $1,927,000.00
- INM $4,920,990.00
- Revenue This Year
- SNES $130.53
- INM N/A
- Revenue Next Year
- SNES $80.00
- INM N/A
- P/E Ratio
- SNES N/A
- INM N/A
- Revenue Growth
- SNES 40.15
- INM N/A
- 52 Week Low
- SNES $1.30
- INM $1.72
- 52 Week High
- SNES $6.48
- INM $15.70
- Technical
- Relative Strength Index (RSI)
- SNES 76.68
- INM 59.24
- Support Level
- SNES $3.56
- INM $2.26
- Resistance Level
- SNES $4.46
- INM $5.50
- Average True Range (ATR)
- SNES 0.38
- INM 0.40
- MACD
- SNES 0.10
- INM 0.11
- Stochastic Oscillator
- SNES 97.61
- INM 37.04
About SNES SenesTech Inc.
SenesTech Inc is a United States-based biotech platform and research company engaged in developing technology for managing animal pest populations through fertility control. The company provides its solutions to the animal market, commercial markets, and food markets. It currently has two product lines of fertility control products: ContraPest and Evolve.
About INM InMed Pharmaceuticals Inc.
InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The company is engaged in the research and development of novel, cannabinoid-based, and manufacturing of Pharmaceutical grade cannabinoids. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; INM-901 for Alzheimer's disease, INM-089's pharmacological and IntegraSyn which is a manufacturing system for Pharmaceutical-Grade Cannabinoids.